SPRB
Spruce Biosciences, Inc.
45.70$
+2.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -8.0% | -15.8% | -13.7% | -13.8% | -30.6% | -30.0% | -31.1% | -29.8% | +246.2% | +5.9% | +83.1% | |
| – | -8.1% | -16.0% | -13.9% | -14.0% | -30.5% | -30.8% | -31.5% | -30.7% | +259.0% | +5.6% | +83.8% | |
| – | -2.5% | -15.8% | -14.1% | -13.8% | -35.5% | -33.9% | -36.0% | -34.9% | +358.4% | +10.6% | +78.1% | |
| – | -10.8% | -15.8% | -14.1% | -13.8% | – | – | -36.0% | -34.9% | +358.4% | +10.6% | +78.1% | |
| – | -0.6% | -23.8% | -21.8% | -17.7% | +21.7% | -0.4% | -47.1% | +14.9% | +5.8% | +104.8% | -11.1% | |
| – | +1.1% | -24.8% | -22.3% | -17.0% | +28.6% | +2.8% | -48.6% | +17.0% | +7.0% | +16.8% | -7.0% | |
| – | +0.4% | +0.4% | +0.4% | +0.4% | – | – | -24.0% | -31.8% | -62.6% | +318.3% | +113.9% | |
| – | +5.7% | -43.2% | -63.9% | +163.8% | -28.0% | +45.1% | -57.1% | +71.7% | -32.0% | +184.5% | -54.9% | |
| – | -18.7% | -23.1% | -30.1% | -43.2% | -76.3% | – | – | – | – | – | -16.0% | |
| – | -10.4% | -12.9% | -11.2% | -12.7% | -44.2% | -46.8% | -14.0% | -59.1% | +689.4% | -18.5% | +141.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.8% | +0.2% | +0.2% | +0.3% | +4.9% | +1.5% | +6.1% | -7.1% | +36.1% | +79.0% | +77.2% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.